- Home /
- Press /
- Press releases /
- Detail
Eckert & Ziegler Receives Technetium Generator Licenses for Brazil
Insider information pursuant to Article 17 MAR
Sao Paulo, 12 April 2021 - The Brazilian regulator ANVISA has provided Eckert & Ziegler Brasil Comercial Ltda., a fully owned subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), with a license to import and distribute technetium generators. This is the second license ever given to an organization in Brazil, and only the first one for a private company. Technetium generators are a core component for a nuclear imaging procedure called SPECT, which is used for the detection of medical abnormalities. In Brazil, the SPECT market has a volume of about 100 mm Euro annually. Eckert & Ziegler already services about 500 hospitals and clinics in this country with medical devices and radioisotopes, and hopes to start shipping SPECT products in the third quarter of 2021. |
Information and Explanation of the Issuer to this News:
Claudia Goulart, CEO of Eckert & Ziegler Brasil, commented: 'We are very excited that Eckert & Ziegler has now been given the opportunity to service the Brazilian nuclear medicine community with SPECT products. It compliments perfectly our existing portfolio of radiopharmaceuticals, among them Lu-177 and O-18, and the services we provide for international pharmaceutical companies'